GFP
SGYP

Gryphon Financial Partners’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Gryphon Financial Partners’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-611
Closed -$1K – 952
2018
Q2 		$1K Buy
+611
New +$1.06K ﹤0.01% 961

Other funds holding SGYP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Gryphon Financial Partners's SGYP Position: Q3 2018 in Review

Gryphon Financial Partners sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2018, closing a stake of 611 shares — an estimated $1K sold.

Gryphon Financial Partners first reported a position in SGYP in Q2 2018 and held it in 1 quarter. The position peaked at $1K in Q2 2018. 134 funds tracked by Wall St. Rank hold SGYP as of Q3 2018.

  • Gryphon Financial Partners reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2018 after selling out during the quarter.
  • Gryphon Financial Partners sold 611 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2018, an estimated $1K.
  • Gryphon Financial Partners first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2018 and held it in 1 quarter.
  • Gryphon Financial Partners's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1K in Q2 2018.
  • 134 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2018.

Based on Gryphon Financial Partners's 13F filing for Q3 2018, filed 6 Nov 2018.